Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phornano is a specialized technology company focused on high-precision 3D microprinting using two-photon polymerization (2PP) for the life sciences and medical device industries. The company develops and manufactures complex micro-structures such as microneedles for transdermal drug delivery, scaffolds for tissue engineering, and micro-optical components for medical imaging. By enabling sub-micron resolution, Phornano's platform allows for the creation of customized, biocompatible components that were previously impossible to manufacture using traditional methods. Their services cater to pharmaceutical companies and research institutions seeking advanced micro-scale solutions for diagnostics, regenerative medicine, and targeted therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PHORNANO Holding.